1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Drug Modelling Software Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Drug Modelling Software Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Adoption of Modelling Tools in Drug Discovery
- 5.1.2 Increasing Economic Burden of Drug Discovery
5.2 Market Opportunities
- 5.2.1 Strategic Activities by Market Players
5.3 Future Trends
- 5.3.1 Growing Adoption of Artificial Intelligence in Drug Discovery
5.4 Impact of Drivers and Restraints
6. North America Drug Modelling Software Market Regional Analysis
6.1 North America Drug Modelling Software Market Overview
6.2 North America Drug Modelling Software Market Revenue 2017-2027 (US$ Million)
6.3 North America Drug Modelling Software Market Forecast Analysis
7. North America Drug Modelling Software Market Analysis – by roduct Type
7.1 Database
- 7.1.1 Overview
- 7.1.2 Database: North America Drug Modelling Software Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Software
- 7.2.1 Overview
- 7.2.2 Software: North America Drug Modelling Software Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Drug Modelling Software Market Analysis – by Application
8.1 Drug Discovery and Development
- 8.1.1 Overview
- 8.1.2 Drug Discovery and Development: North America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Computational Physiological Medicine
- 8.2.1 Overview
- 8.2.2 Computational Physiological Medicine: North America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Disease Modelling
- 8.3.1 Overview
- 8.3.2 Disease Modelling: North America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Medical Imaging
- 8.4.1 Overview
- 8.4.2 Medical Imaging: North America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Predictive Analysis of Drug Targets
- 8.5.1 Overview
- 8.5.2 Predictive Analysis of Drug Targets: North America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Simulation Software
- 8.6.1 Overview
- 8.6.2 Simulation Software: North America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Cellular Simulation
- 8.7.1 Overview
- 8.7.2 Cellular Simulation: North America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Drug Modelling Software Market – North America Analysis
9.1 North America
- 9.1.1 North America Drug Modelling Software Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.1.1.1 North America Drug Modelling Software Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.1.1 US: North America Drug Modelling Software Market Breakdown, by roduct Type
- 9.1.1.1.2 US: North America Drug Modelling Software Market Breakdown, by Application
- 9.1.1.2 Canada:
North America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.2.1 Canada: North America Drug Modelling Software Market Breakdown, by roduct Type
- 9.1.1.2.2 Canada: North America Drug Modelling Software Market Breakdown, by Application
- 9.1.1.3 Mexico :
North America Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.3.1 Mexico : North America Drug Modelling Software Market Breakdown, by roduct Type
- 9.1.1.3.2 Mexico : North America Drug Modelling Software Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Drug Modelling Software Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Crown Bioscience Inc (JSR life science)
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Chemical Computing Group ULC
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Nimbus Therapeutics
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Schrödinger, Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Leadscope, Inc (Instem)
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For North America Drug Modelling Software Market
